Literature DB >> 23968687

Miltefosine resistance in Leishmania donovani involves suppression of oxidative stress-induced programmed cell death.

Jyotsna Mishra1, Sarman Singh.   

Abstract

Miltefosine (MIL), an alkylphospholipid, is the first orally administrable anti-leishmanial drug. But due to its long half-life, miltefosine is highly vulnerable for resistance. Hence it is important to understand the mechanism of resistance and to elucidate its action on Leishmania. Here we investigate the miltefosine induced process of programmed cell death in wild type (miltefosine sensitive) and in laboratory generated resistant strains of Leishmania donovani. Results indicate that miltefosine induced apoptosis like death in a time and dose dependent manner in wild-type cells, but not in MIL-resistant cell line. The miltefosine resistant cells remained protected against miltefosine-induced loss of mitochondrial membrane potential, gradual ATP loss and cytochrome C release from mitochondria into the cytosol. Comparative transcriptomic study showed significantly increased expression of FeSODA and SIR2 genes, putatively involved in oxidative stress associated apoptotic cell death. We hypothesize that oxidative stress mediated apoptosis as an alternative mechanism of miltefosine resistance.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Leishmania donovani; Miltefosine resistance; Oxidative stress; Visceral leishmaniasis

Mesh:

Substances:

Year:  2013        PMID: 23968687     DOI: 10.1016/j.exppara.2013.08.004

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  23 in total

1.  Reduction of Toxoplasma gondii Development Due to Inhibition of Parasite Antioxidant Enzymes by a Dinuclear Iron(III) Compound.

Authors:  J A Portes; T G Souza; T A T dos Santos; L L R da Silva; T P Ribeiro; M D Pereira; A Horn; C Fernandes; R A DaMatta; W de Souza; S H Seabra
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

2.  Functional Involvement of Leishmania donovani Tryparedoxin Peroxidases during Infection and Drug Treatment.

Authors:  Sanchita Das; Sagnik Giri; Shyam Sundar; Chandrima Shaha
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

3.  In Vivo Selection of Paromomycin and Miltefosine Resistance in Leishmania donovani and L. infantum in a Syrian Hamster Model.

Authors:  S Hendrickx; A Mondelaers; E Eberhardt; P Delputte; P Cos; L Maes
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

4.  New Insights into the Mechanism of Action of the Cyclopalladated Complex (CP2) in Leishmania: Calcium Dysregulation, Mitochondrial Dysfunction, and Cell Death.

Authors:  Angela M A Velásquez; Paula J Bartlett; Irwin A P Linares; Thais G Passalacqua; Daphne D L Teodoro; Kely B Imamura; Stela Virgilio; Luiz R O Tosi; Aline de Lima Leite; Marilia A R Buzalaf; Jecika M Velasques; Adelino V G Netto; Andrew P Thomas; Marcia A S Graminha
Journal:  Antimicrob Agents Chemother       Date:  2021-10-11       Impact factor: 5.938

5.  Antifungal Activity of Oleylphosphocholine on In Vitro and In Vivo Candida albicans Biofilms.

Authors:  Michelle Holtappels; Erwin Swinnen; Lies De Groef; Jurgen Wuyts; Lieve Moons; Katrien Lagrou; Patrick Van Dijck; Soňa Kucharíková
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

6.  A versatile qPCR assay to quantify trypanosomatidic infections of host cells and tissues.

Authors:  Eugenia Bifeld; Paloma Tejera Nevado; Janika Bartsch; Julia Eick; Joachim Clos
Journal:  Med Microbiol Immunol       Date:  2016-06-09       Impact factor: 3.402

7.  Host-mediated Leishmania donovani treatment using AR-12 encapsulated in acetalated dextran microparticles.

Authors:  M A Collier; K J Peine; S Gautam; S Oghumu; S Varikuti; H Borteh; T L Papenfuss; A R Sataoskar; E M Bachelder; K M Ainslie
Journal:  Int J Pharm       Date:  2016-01-05       Impact factor: 5.875

8.  Lipase Precursor-Like Protein Promotes Miltefosine Tolerance in Leishmania donovani by Enhancing Parasite Infectivity and Eliciting Anti-inflammatory Responses in Host Macrophages.

Authors:  Deepak Kumar Deep; Ruchi Singh; Arpita Kulshrestha; Saima Wajid; Poonam Salotra
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

9.  A mitochondrial HSP70 (HSPA9B) is linked to miltefosine resistance and stress response in Leishmania donovani.

Authors:  P Vacchina; B Norris-Mullins; E S Carlson; M A Morales
Journal:  Parasit Vectors       Date:  2016-12-01       Impact factor: 3.876

10.  Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India.

Authors:  Saumya Srivastava; Jyotsna Mishra; Anil Kumar Gupta; Amit Singh; Prem Shankar; Sarman Singh
Journal:  Parasit Vectors       Date:  2017-01-31       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.